Rutgers: A Common Antihistamine Shows Promise in Treating Liver Complications of a Rare Disease
January 17, 2025
January 17, 2025
NEW BRUNSWICK, New Jersey, Jan. 17 (TNSres) -- Rutgers University issued the following news:
By Andrew Smith
A common antihistamine may offer hope for patients with a rare genetic disease that can lead to severe liver damage and ultimately require transplantation, according to new research from Rutgers Health.
The study in Cellular and Molecular Gastroenterology and Hepatology found that chlorcyclizine, a decades-old allergy medication, could potentially tr . . .
By Andrew Smith
A common antihistamine may offer hope for patients with a rare genetic disease that can lead to severe liver damage and ultimately require transplantation, according to new research from Rutgers Health.
The study in Cellular and Molecular Gastroenterology and Hepatology found that chlorcyclizine, a decades-old allergy medication, could potentially tr . . .